Abstract
SmithKline Beecham (SBPI) is a major player in the Indian pharmaceutical industry. Though relatively small in terms of turnover, it has performed Pharmaceuticals (India) exceptionally well in terms ofprofitability and growth rate. The firm has substantial cash reserves. However, the firm operates in 'mass production' mode at present, with the established finished goods inventory norms being in the range of 1 to 1.5 months. Competitive pressure on the firm is now forcing it to move towards world class manufacturing and the application of concepts from MRP II, JIT and OPT is under consideration. This paper describes the considerations that went into the justification, design and implementation of an integrated production planning and control system in this situaion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
